PC67
Anti-Bcl-x L (Ab-1) (201-216) Rabbit pAb
Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
About This Item
Forme d'anticorps
purified antibody
Niveau de qualité
Clone
polyclonal
Forme
liquid
Contient
≤0.1% sodium azide as preservative
Espèces réactives
rat, human, opossum, mouse
Isotype
IgG
Description générale
Purified rabbit polyclonal antibody. Recognizes the ~28 kDa Bcl-x protein.
Recognizes the ~28 kDa Bcl-x protein in doxorubicin-treated MCF-7 cells.
bcl-x is a bcl-2-related gene that can function as a regulator of programmed cell death (apoptosis) independent of bcl-2. Alternative splicing results in two distinct bcl-x mRNAs, bcl-xL and bcl-xS. The larger mRNA gives rise to a protein product, bcl-xL, which is similar in size and predicted structure to bcl-2. bcl-x immunoreactivity has been detected in a wide variety of cell types and the protein is typically present in the cytosol in association with the mitochondrial periphery, a property shared with bcl-2. Of the two isoforms of bcl-x, the long (bcl-xL) is the most abundant mRNA species expressed in embryonic and adult tissues and most likely differs from bcl-2 in its regulatory activity on cell differentiation through controlled tissue specific expression. Like its homolog bcl-2, the mechanism and extent of bcl-x′s function are still increasing. bcl-xL has been shown to modify the cell′s response to oxidants as well as to participate in resistance to chemotherapeutic agents and radiation.
Immunogène
a synthetic peptide (PWIQENGGWDTFVELY) corresponding to amino acids 201-216 of human Bcl-x
Application
Frozen Sections (5 μg/ml)
Immunoblotting (2.5 μg/ml, chemiluminescence)
Paraffin Sections (2.5 μg/ml, pressure cooker pre-treatment required)
Immunoblotting (2.5 μg/ml, chemiluminescence)
Paraffin Sections (2.5 μg/ml, pressure cooker pre-treatment required)
Forme physique
In 50 mM sodium phosphate buffer, 0.2% gelatin, pH 7.5.
Remarque sur l'analyse
Negative Control
Brain tissue
Brain tissue
Positive Control
Doxorybicin-treated MCF-7 cells (see comments) or intestinal tissue
Doxorybicin-treated MCF-7 cells (see comments) or intestinal tissue
Autres remarques
The immunoblotting application applies to human samples only. Mouse and rat frozen intestinal tissue was fixed with Zamboni′s fixative prior to staining. Only random cells will stain for bcl-x in brain tissue. For MCF-7 cells as a positive control, stimul
Code de la classe de stockage
10 - Combustible liquids
Classe de danger pour l'eau (WGK)
WGK 1
Point d'éclair (°F)
Not applicable
Point d'éclair (°C)
Not applicable
Certificats d'analyse (COA)
Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
M González-García et al.
Development (Cambridge, England), 120(10), 3033-3042 (1994-10-01)
Most examples of cell death in animals are controlled by a genetic program that is activated within the dying cell. The apoptotic process is further regulated by a set of genes that act as repressors of cell death. Of these
L H Boise et al.
Cell, 74(4), 597-608 (1993-08-27)
We report the isolation of bcl-x, a bcl-2-related gene that can function as a bcl-2-independent regulator of programmed cell death (apoptosis). Alternative splicing results in two distinct bcl-x mRNAs. The protein product of the larger mRNA, bcl-xL, is similar in
W Fang et al.
Journal of immunology (Baltimore, Md. : 1950), 155(1), 66-75 (1995-07-01)
Developing lymphocytes undergo extensive cell death during selection of the immune repertoire. We investigated the influence of bcl-xL, a member of the bcl-2 family of apoptosis regulatory genes, on apoptosis in a model system for negative selection in the B
S Krajewski et al.
Cancer research, 54(21), 5501-5507 (1994-11-01)
The in vivo patterns of bcl-X gene expression were assessed in human and mouse tissues using an immunohistochemical approach. Polyclonal antisera were raised against synthetic peptides corresponding to amino acids 46-66 and 61-79 of the human Bcl-X protein and were
R Datta et al.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 6(4), 363-370 (1995-04-01)
Acquired resistance to diverse chemotherapeutic agents has been associated with overexpression of the P-glycoprotein. We have selected human U-937 cells for clones resistant to the cytotoxic agents doxorubicin (U-A20) and vincristine (U-V20). The results demonstrate that P-glycoprotein-positive U-A20 and U-V20
Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..
Contacter notre Service technique